Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia

This publication has 37 references indexed in Scilit:

• Familial Hypercholesterolemia in the Finnish North Karelia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach
  Current Opinion in Lipidology, 1996
• Influence of genetic variability in the nondeletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a ‘null’ LDL-receptor gene defect
  Atherosclerosis, 1996
• Determinants of Lipid Levels Among Children With Heterozygous Familial Hypercholesterolemia in Norway
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia
  Atherosclerosis, 1990
• Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia
  The Lancet, 1990
• Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese
  Atherosclerosis, 1990
• Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1990
• Familial hypercholesterolemia and apolipoprotein E4
  Atherosclerosis, 1988